Palomino Laboratories (PALX) Income from Continuing Operations (2023 - 2025)

Palomino Laboratories (PALX) has 3 years of Income from Continuing Operations data on file, last reported at 1605860.0 in Q3 2025.

• For the quarter ending Q3 2025, Income from Continuing Operations fell 143536.85% year-over-year to 1605860.0; the trailing twelve-month figure through Sep 2025 stood at 1811729.0 (down 893.59% YoY), and the FY2024 full-year result was 145866.0, down 22.73% from the prior year.
• Income from Continuing Operations retreated to 1605860.0 in Q3 2025, from 43775.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 1118.0 in Q3 2024 to a low of 1605860.0 in Q3 2025.
• A 3-year average of 226325.89 and a median of 51304.0 in 2024 frame the typical range for Income from Continuing Operations.
• Across the five-year window, Income from Continuing Operations surged 97.39% in 2024 and sank 143536.85% in 2025, its largest moves.
• Tracing PALX's Income from Continuing Operations over 3 years: stood at 67487.0 in 2023, then tumbled by 102.91% to 136938.0 in 2024, then slumped by 1072.69% to 1605860.0 in 2025.
• Business Quant data shows PALX's Income from Continuing Operations at 1605860.0 in Q3 2025, 43775.0 in Q2 2025, and 25156.0 in Q1 2025.